🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nebojša Skorupan

National Institutes of Health

ORCID: 0000-0003-0854-3360

Also affiliated with National Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas”.

A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas

Future Oncology(2022)10.2217/fon-2021-1609

N/A

1.1DataRank · unranked

43 citations

Mehwish Ahmad, Seth M. Steinberg, Jane B. Trepel, Derek Cridebring, Haiyong Han +3 more

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

Frontiers in Oncology(2024)10.3389/fonc.2024.1386190

N/A

0.421DataRank · unranked

9 citations

Cody J. Peer, Xianyu Zhang, Hyoyoung Choo‐Wosoba, Mehwish Ahmad, Min-Jung Lee +13 more

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment

Translational Oncology(2022)10.1016/j.tranon.2022.101440

N/A

0.416DataRank · unranked

15 citations

Yunkai Yu, Cody J. Peer, Rebekah Landsman, Nebojša Skorupan, Liang Cao +2 more

Analysis of systemic immune changes in patients with advanced cancer treated with immunotoxin LMB-100 and tofacitinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15017

N/A

0DataRank · unranked

1 citations

Cody J. Peer, Yunkai Yu, Min-Jung Lee, Sunmin Lee, Shraddha Rastogi +10 more

Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers

Cancer Letters(2025)10.1016/j.canlet.2025.217975

N/A

0DataRank · unranked

3 citations

Joy Awosika, Cecilia Monge, Kelley Coffman, Changqing Xie, Nebojša Skorupan +13 more

Phase I study of mesothelin-targeted immunotoxin LMB-100 in combination with tofacitinib in patients with advanced pancreatobiliary cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3051

N/A

0DataRank · unranked

4 citations

Mehwish Ahmad, Guillaume Joe Pegna, Cody J. Peer, Jane B. Trepel, Min-Jung Lee +9 more

Hepatic lymph node metastases in patients with colorectal liver metastases undergoing hepatic artery infusion pump placement

Annals of Hepato-Biliary-Pancreatic Surgery(2025)10.14701/ahbps.25-158

N/A

0DataRank · unranked

0 citations

Alyssa V. Eade, Kyle Hitscherich, Cathleen Hannah, Nebojša Skorupan, Lindsay R. Friedman +5 more

Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma

Cancers(2022)10.3390/cancers14174209

N/A

0DataRank · unranked

30 citations

Mayrel Palestino Domínguez, Samuel L. Ricci, Christine Alewine, Nebojša Skorupan

Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?

Journal of Cancer Metastasis and Treatment(2023)10.20517/2394-4722.2022.106

N/A

0DataRank · unranked

10 citations

Shadin Ghabra, J. Alberto Maldonado, Yang Zhang, Christine Alewine, Nebojša Skorupan